Replies to post #4126 on Inovio Pharmaceuticals Inc (INO)

[KR_redondo]

Tempered by the number of DNA vaccines ? DNA vaccines are just now starting to show the amount of immune responses needed to be clincally significant to make it to market, this has been triggered by improvements in the delivery technology thats why big pharma has been acquiring companies associated with this new generation of DNA vaccines to suggest there is a cap on that holds no weight. When personal computers came out people thought there was no way every could afford to own and it wouldn't be accessible people put a cap on how profitable a computer company can be..the fact was an industry was being revolutionized much like medicine is going through now..you know the rest of the story anyways if 1 of 11 clinical trials actually have a decent chance of making it to market then Inos pipeline might be one of the safest bet.